7 completed. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 7 |
Follow Olfaction Disorders: new trials by email Literature Review of Olfaction Disorders trials Research Report on Olfaction Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olfactory Disfunction and Co-ultraPEALut co-ultraPEALut, Olfactory Rehab, PEA-LUT 1 sachet - Anosmia, Covid19 | Phase 4 | Completed | University Of Perugia | 200 | 2020-11-15 | 2022-11-16 |
| BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19 BNO 1030, Standard care - Covid19, Nasopharyngitis | Phase 4 | Completed | Ivano-Frankivsk National Medical University | 133 | 2020-05-01 | 2021-03-15 |
| Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly Donepezil - Alzheimer Disease, Mild Cognitive Impairment | Phase 4 | Completed | New York State Psychiatric Institute | 121 | 2013-10-01 | 2020-07-13 |
| Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil Donepezil, Atropine - Mild Cognitive Impairment | Phase 4 | Completed | New York State Psychiatric Institute | 41 | 2012-08-01 | 2018-07-09 |
| Taste, Smell and Chemotherapy (TASTY) Dexa scan, audiogram, measurement of heart rate variability and baroreflex sensitivity - Testicular Cancer | Phase 4 | Completed | University Medical Center Groningen | 140 | 2012-06-01 | 2024-04-19 |
| Olfaction in Patients With Parkinson's Disease Following Treatment With Rasagiline Azilect 1mg, Placebo - Parkinson´s Disease | Phase 4 | Completed | Technische Universität Dresden | 34 | 2009-05-01 | 2012-02-07 |
| Effect of Postoperative Additive Systemic Steroids in CRSwNP Systemic Steroid (Prednisolone), Placebo - Sinusitis, Chronic | Phase 4 | Completed | Friedrich-Alexander-Universität Erlangen-Nürnberg | 106 | 2005-01-18 | 2021-06-07 |
Anosmia (7) · Alzheimer Disease (2) · COVID-19 (2) · Cognitive Dysfunction (2) · Bronchiolitis Obliterans Syndrome (1) · Cognition Disorders (1) · Cough (1) · Fever (1) · Myalgia (1) · Nasal Obstruction (1) · Nasopharyngitis (1) · Neoplasms (1) · Neurocognitive Disorders (1) · Parkinson Disease (1)
Nervous System Diseases (7) · Neurologic Manifestations (7) · Pathological Conditions, Signs and Symptoms (7) · Sensation Disorders (7) · Signs and Symptoms (7) · Brain Diseases (3) · Central Nervous System Diseases (3) · Infections (3) · Lung Diseases (3) · Neurodegenerative Diseases (3) · Respiratory Tract Diseases (3) · Respiratory Tract Infections (3) · Coronaviridae Infections (2) · Coronavirus Infections (2)
Donepezil (2) · Absorptiometry, Photon (1) · Atropine (1) · Hearing (1) · Prednisolone (1) · Standard of Care (1) · co-ultraPEALut (1) · imupret (1) · rasagiline (1)
New York State Psychiatric Institute (2) · Friedrich-Alexander-Universität Erlangen-Nürnberg (1) · Ivano-Frankivsk National Medical University (1) · Technische Universität Dresden (1) · University Medical Center Groningen (1) · University Of Perugia (1)
United States (2) · Germany (1) · Italy (1) · Netherlands (1) · Ukraine (1)
Davangere Devanand, M.D. (2) · A KL Reyners, MD, PhD (1) · Gregory Pelton, M.D. (1) · Heinz Reichmann, MD, PhD (1) · Vasyl Popovych, Professor (1)
PMID 32333591, PMID 36062970, PMID 37990964
2008 (1), R01AG041795 (1)